Bedfordshire and Luton Joint Prescribing Committee
Ref: JPC Bulletin 242 (last updated Feb 2020)
Bulletin Date: 26/02/20
Review Date: February 2023
Bulletin 242: Low Molecular Weight Heparins (LMWHs), Fondaparinux and Novel Oral Anticoagulants – Prescribing Guidance and Responsibilities
To support the prescribing and monitoring of treatment and prophylactic doses of LMWHs, Fondaparinux and NOACs across the primary/secondary care interface for venous thromboembolism (VTE).
To support primary care prescribers in the governance and safety of initiating and/or continuing the prescribing of these agents.
- Define the place in therapy of LMWH, Fondaparinux and NOACs for primary care prescribers.
- Identify who is responsible for the initiation and continued supply (where relevant) of these agents thereby minimising confusion.
- Ensure that these agents are used safely and appropriately across Bedfordshire and Luton CCGs.
See attached bulletin for full details